Conforti F, Holtschmidt J, Nekljudova V, Sala I, et al. Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials. Lancet Oncol 2025;26:1584-1597.
PMID: 41308675